Taichi Isobe

Dr. Taichi Isobe

Kyushu University
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2014 in eLife
Verified
Journal Article
Open access
TITaichi Isobe
Taichi Isobe
SHShigeo Hisamori
Shigeo Hisamori
DHDaniel J Hogan
Daniel J Hogan
MZMaider Zabala
Maider Zabala
DHDavid G Hendrickson
David G Hendrickson
YSYohei Shimono
Yohei Shimono
MicroRNAs (miRNAs) are important regulators of stem and progenitor cell functions. We previously reported that miR-142 and miR-150 are upregulated in human breast cancer stem cells (BCSCs) as compared to the non-tumorigenic breast cancer cells. In this study, we report that miR-142 efficiently recruits the APC mRNA to an RNA-induced silencing complex, activates the canonical WNT signaling pathway in an APC-suppression dependent manner, and activates the expression of miR-150. Enforced expression of miR-142 or miR-150 in normal mouse mammary stem cells resulted in the regeneration of hyperproliferative mammary glands in vivo. Knockdown of endogenous miR-142 effectively suppressed organoid formation by BCSCs and slowed tumor growth initiated by human BCSCs in vivo. These results suggest that in some tumors, miR-142 regulates the properties of BCSCs at least in part by activating the WNT signaling pathway and miR-150 expression.

15 October 2019 in Cancer Research
Verified
Journal Article
Closed access
PDF file
JMJunko Mukohyama
Junko Mukohyama
TITaichi Isobe
Taichi Isobe
QHQingjiang Hu
Qingjiang Hu
THTakanori Hayashi
Takanori Hayashi
TWTakashi Watanabe
Takashi Watanabe
YSYohei Shimono
Yohei Shimono
MiRNAs are key players in the integrated regulation of cellular processes and shape many of the functional properties that define the “cancer stem cell” (CSC) phenotype. Little is known, however, about miRNAs that regulate such properties in human colorectal carcinoma. In this study, we compared the expression levels of 754 miRNAs between paired samples of EpCAM+/CD44+ cancer cells (enriched in CSCs) and EpCAM+/CD44neg cancer cells (with CSC depletion) sorted in parallel from human primary colorectal carcinomas and identified miR-221 as the miRNA that displayed the highest level of preferential expression in EpCAM+/CD44+ cancer cells. High levels of miR-221 expression were associated with Lgr5+ cells in mouse colon crypts and reduced survival in patients with colorectal carcinoma. Constitutive overexpression of miR-221 enhanced organoid-forming capacity of both conventional colorectal carcinoma cell lines and patient-derived xenografts (PDX) in vitro. Importantly, constitutive downregulation of miR-221 suppressed organoid-forming capacity in vitro and substantially reduced the tumorigenic capacity of CSC populations from PDX lines in vivo. Finally, the most abundant splicing isoform of the human Quaking (QKI) gene, QKI-5, was identified as a functional target of miR-221; overexpression of miR-221–reduced QKI-5 protein levels in human colorectal carcinoma cells. As expected, overexpression of QKI-5 suppressed organoid-forming capacity in vitro and tumorigenic capacity of colorectal carcinoma PDX cells in vivo. Our study reveals a mechanistic link between miR-221 and QKI and highlights their key role in regulating CSC properties in human colorectal cancer. Significance: These findings uncover molecular mechanisms underlying the maintenance of cancer stem cell properties in colon cancer. Graphical http://cancerres.aacrjournals.org/content/canres/79/20/5151/F1.large.jpg. Graphical Abstract

19 October 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
KTKenro Tanoue
Kenro Tanoue
HOHirofumi Ohmura
Hirofumi Ohmura
KUKoki Uehara
Koki Uehara
MIMamoru Ito
Mamoru Ito
KYKyoko Yamaguchi
Kyoko Yamaguchi
EBEishi Baba
Eishi Baba
Despite the success of immune checkpoint blockade (ICB) therapy for esophageal squamous cell cancer, the key immune cell populations that affect ICB efficacy remain unclear. Here, imaging mass cytometry of tumor tissues from ICB-treated patients identifies a distinct cell population of CD39+PD-1+CD8+ T cells, specifically the TCF1+ subset, precursor exhausted T (CD39+ Tpex) cells, which positively correlate with ICB benefit. CD39+ Tpex cells are predominantly in the stroma, while differentiated CD39+ exhausted T cells are abundantly and proximally within the parenchyma. Notably, CD39+ Tpex cells are concentrated within and around tertiary lymphoid structure (TLS). Accordingly, tumors harboring TLSs have more of these cells in tumor areas than tumors lacking TLSs, suggesting Tpex cell recruitment from TLSs to tumors. In addition, circulating CD39+ Tpex cells are also increased in responders following ICB therapy. Our findings show that this unique subpopulation of CD39+PD-1+CD8+ T cells is crucial for ICB benefit, and suggest a key role in TLS-mediated immune responses against tumors.

18 April 2008 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
SAShuji Arita
Shuji Arita
EBEishi Baba
Eishi Baba
YSYoshihiro Shibata
Yoshihiro Shibata
HNHiroaki Niiro
Hiroaki Niiro
SSShinji Shimoda
Shinji Shimoda
MHMine Harada
Mine Harada
Exosomes are nanovesicles produced constitutively and inducibly by several types of cells. They are generated as intraluminal vesicles of multivesicular bodies and express MHC and several endosomal/lysosomal proteins. In spite of their potential role in cellular immunity, the regulatory mechanisms of exosome production are largely unknown. In this study, we have established a novel ELISA system to quantify exosomal HLA using a combination of anti‐HLA class I and anti‐HLA‐DR mAb. We found that exosomal HLA production of B cells was enhanced by contact with CD4+ T cells. Neutralizing anti‐CD154 (CD40L) mAb inhibited this effect, and a soluble CD40L significantly increased production of exosomal HLA in B cells. In addition, B cell stimulation via BCR and TLR9 enhanced their production while IL‐4 stimulation alone failed to do so. Strikingly, an inhibitor of the classical NF‐κB pathway drastically inhibited exosomal HLA production in stimulated B cells, indicating that the classical NF‐κB pathway is critical for exosomal HLA production in B cells. Together, these findings suggest a pivotal role of B cell activation in exosomal HLA production in vivo.See accompanying article: http://dx.doi.org/10.1002/eji200838374

1 November 2011 in Experimental Cell Research
Verified
Journal Article
Closed access
TITaichi Isobe
Taichi Isobe
EBEishi Baba
Eishi Baba
SAShuji Arita
Shuji Arita
MKMasato Komoda
Masato Komoda
STShingo Tamura
Shingo Tamura
KAKoichi Akashi
Koichi Akashi

24 May 2018 in Oncology Reports
Verified
Journal Article
Open access
PDF file
STShingo Tamura
Shingo Tamura
TITaichi Isobe
Taichi Isobe
HAHiroshi Ariyama
Hiroshi Ariyama
MNMichitaka Nakano
Michitaka Nakano
YKYoshikane Kikushige
Yoshikane Kikushige
EBEishi Baba
Eishi Baba
Cancer stem cells (CSCs) possess a self‑renewal ability and display tumorigenic potential in immunodeficient mice. Colorectal CSCs are thought to be a uniform population and no functionally distinct subpopulations have been identified. Because E‑cadherin is an essential molecule for self‑renewal of embryonic stem cells, we examined E‑cadherin expression, which may play a role in maintaining the properties of CSCs, in EpCAMhigh/CD44+ colorectal CSCs from human primary colorectal cancers. We obtained 18 surgical specimens of human primary colorectal cancer. CD44, EpCAM, and E‑cadherin expression were analyzed by fluorescence‑activated cell sorting. Sorted EpCAMhigh/CD44+ colorectal CSCs were injected into immunodeficient mice to estimate the tumorigenic potential. Genetic profiles were analyzed by cDNA microarray. Notably, colorectal CSCs could be divided into two populations based on the E‑cadherin expression status, and they exhibited different pathological characteristics. Compared to E‑cadherin‑negative colorectal CSCs, E‑cadherin‑positive (EC+) colorectal CSCs demonstrated higher tumor growth potential in vivo. EC+ colorectal CSCs revealed a higher expression of the pluripotency factor NANOG, which contributed to the higher tumor growth potential of EC+ colorectal CSCs through control of cyclin D1 expression. These findings are the first demonstration of functionally distinct subpopulations of colorectal CSCs in human clinical samples.